Chemical and Biomolecular Research Papers -- Faculty Authors Series
William H. Velander Publications
Professor, Department Chair
Department of Chemical & Biomolecular Engineering
College of Engineering, University of Nebraska–Lincoln
207B OTHM Lincoln NE 68588-0643
Email: wvelander2@unl.edu
Research Interests: Working on safer, abundant sources of plasma-derived medicines since 1987, when disease contamination of blood supply medicines by HIV, Hepatitis B and C reached a worldwide epidemic.
2006
Transgenic fibrinogen, Dr. William H. Velander
2005
Secretion of Recombinant Human fibrinogen by the Murine Mammary Gland, Dr.William H. Velander
Secretion of Recombinant Human fibrinogen by the Murine Mammary Gland, Dr.William H. Velander
cGMP Recombinant FIX for IV and Oral Hemophilia B Therapy, William H. Velander PRINCIPAL INVESTIGATOR, Abramson Stephan LEAD INVESTIGATOR, Cooper Julian LEAD INVESTIGATOR, William Dernell KEY PERSON, Mark Manning LEAD INVESTIGATOR, Michael Meagher LEAD INVESTIGATOR, Paul Mohanan LEAD INVESTIGATOR, Timothy Nichols LEAD INVESTIGATOR, Todd Swaanson KEY PERSON, and Kevin Van Cott LEAD INVESTIGATOR
2004
Haemophilic Factors Produced by Transgenic Livestock: Abundance that can enable alternative therapies worldwide, Kevin Van Cott, Paul E. Monahan, Timothy C. Nichols, and William H. Velander
2003
Transgenic non-human mammals expressing human coagulation factor VIII and von Willebrand factor , Henryk Lubon, William N. Drohan, and William H. Velander
Transgenic non-human mammals expressing human coagulation factor VIII and von Willebrand factor , William H. Velander
2002
Expression of active human factor IX in mammary tissue and of milk non human transgenic mammals, William H. Velander
Expression of active human factor IX in mammary tissue and of milk non human transgenic mammals , William H. Velander and William N. Drohan
2001
Expression of a heterologous protein C in mammary tissue of transgenic animals using a long whey acidic protein promoter , William H. Velander
Immunosorbents with developed binding efficiency and method of manufacture , William H. Velander
Transgenic non-human mammals expressing human coagulation factor VIII and von Willebrand factor , William H. Velander
Expression of a heterologous protein C in mammary tissue of transgenic animals using a long whey acidic protein promoter , William H. Velander, Henryk Lubton, William N. Drohan, and Lothar Hennighausen
2000
Ranking the Factors Impacting lmmunosorbent Performance, Anuradha Subramanian and William H. Velander
1999
Bovine Follicular Dynamics, Oocyte Recovery,and Development of Oocytes Microinjected with a Green Fluorescent Protein Construct, M S CHAUHAN, S Nadir, T L. Bailey, A W. Pryor, S P. Butler, D R. Notter, William H. Velander, and F C. Gwazdauskas
Method of coupling ligands onto supports and products produced therefrom , William H. Velander
Method of coupling ligands onto supports and products produced therefrom , William H. Velander
Transgenic mammals expressing human coagulation factor VIII , William H. Velander
Method of coupling ligands onto supports and products produced therefrom , William H. Velander and Anuradha Subramanian
Inside-out crosslinked and commercial-scale hydrogels, and sub-macromolecular selective purification using the hyrdogels , William H. Velander and Kevin Van Cott
1996
Effect of Antibody Orientation on Immunosorbent, Anuradha Subramanian and William H. Velander
Affinity Purification of Biologically Active andInactive Forms of Recombinant Human Protein C Produced in Porcine Mammary Gland, Kevin Van Cott; Barry Williams Department of Chemical Engineering,Virginia Tech University, Blacksburg, VA 24061, USA; William H. Velander; Francis C. Gwazdauskas; Tim Lee Jerome Holland Laboratory, American Red Cross, Rockville, MD 20855, USA; Henryk Lubon; and William N. Drohan
Expression of human protein C in mammary tissue of transgenic mammals , William H. Velander
Polyelectrolyte DNA conjugation and genetic transformation of an animal , William H. Velander
1992
High-level expression of a heterologous protein in the milk of transgenic swine using the cDNA encoding human protein C, Dr. William H. Velander, John L. Johnson, Raymond L. Page, Christopher G. Russell, Anuradha Subramanian, Tracy D. Wilkins, Francis C. Gwazdauskas, Christoph Pittius, and William N. Drohan